According to media reports, Pfizer has reduced targets for the delivery of the coronavirus vaccine due to supply chain problems. Now half of the original amount is expected Wall Street Thursday. The background is the inadequate quality of the raw materials. The statement of the American pharmaceutical company was initially not available.
Pfizer initially targeted 100 million cans for 2020, then halved the number to 50 million in the past few weeks. Pfizer is developing a vaccine together with BioNTech from Germany.
The news weighed on the US stock trade, which was just 2.4 percent below Wall Street just before the close on Wall Street. The US Dow Jones Standard Value Index has waived its initial gains.